Expression and role of vascular endothelial growth factor and its receptors in acute myeloid leukemia with normal cytogenetics

Ying HAN,Jing-de CHEN,Yi ZHANG,Lan-jun BO,Jian-fei FU,Wen-jun ZHANG,Fei WANG,Zhong-chuan QIU,Ai-bin LIANG
DOI: https://doi.org/10.3760/cma.j.issn.1673-419X.2008.05.003
2008-01-01
Abstract:Objective To evaluate the expression and role of vascular endothelial growth factor (VEGF) and its receptors ( KDR and Flt1) in acute myeloid leukemia with normal cytogenetics (NC- AML). Methods The expression and abundance of VEGF and its receptors mRNA were assayed by RT- PCR and fluorescent quantitative RT-PCR (FQ-RT-PCR). Results Among 45 NC-AML patients, the positive rate of VEGF,KDR and FLt1 mRNA in the bone marrow mononuclear cells (BMMNC) were 93.3% ,75.6% and 82.2% ,respectively. However,the expression of VEGF,KDR and FLt1 mRNA in 10 health people was negative. Real time PCR confirmed the significant variation (P<0. 05) of the VEGF expression if the patient received a chemo therapy. In patients with complete remission(CR), the VEGF expression of VEGF was lower than pre-treatment but still remained relatively higher compared with 10 health people (P<0. 05). However, there was no significant difference for VEGF receptor expression, its receptors had no such significant difference. Conclusion VEGF and its receptors (KDR and Flt1) mRNAs were expressed distinctively in NC-AML ,while the VEGF shows higher levels. Thus ,the assay of VEGF expression levels is of great significance to evaluate the progression, the indication of prognosis and the monitor of micro residual disease.
What problem does this paper attempt to address?